|
|
4545 Towne Centre Court
San Diego, CA 92121 USA
phone:
800-455-1476
fax:
858-909-2000 |
| Symbol |
NUVA |
| Exchange |
Nasdaq |
| Founded |
1997 |
| Employees |
105 |
|
|
www.nuvasive.com |
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Products for the surgical treatment of spine disorders.
|
 |
| Management |
| Alexis V. Lukianov; Keith Valentine; Kevin C. O'Boyle; Pat Miles; Jeffrey Rydin; Jason Hannon; Jonathan D. Spangler; G. Bryan Cornwall phD.P.Eng.; Lisa Brockman |
|
|
|
|
| Keywords |
| reconstruction, orthopedics |
|
|
|
|
Description |
| NuVasive focuses on the design, development and marketing of products for the surgical treatment of spine disorders. |
 |
| Products / Services |
NuVasive's principal product offerings include a surgical platform called Maximum Access Surgery (MAS) and classic fusion products. MAS combines NeuroVision, a nerve avoidance system, MaXcess, a unique split-blade design retraction system, and specialized implants such as CoRoent and SpheRx Pedicle Screw System. NuVasive's classic fusion portfolio is comprised predominantly of proprietary saline-packaged bone allografts, metal mesh cages and fusion plates. The company began commercializing its products in 2001.
|
 |
| Technology / Differentiation |
| The MAS platform offers advantages for both patients and surgeons, including reduced surgery and hospitalization time and faster recovery. MAS products are designed to collectively minimize soft tissue disruption during spine surgery, while allowing maximum visualization and surgical reproducibility. |
 |
 |
|
|
|
|